EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Otsuka Holdings Co's enterprise value is €20,239 Mil.
Otsuka Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was €2,962 Mil. Therefore, Otsuka Holdings Co's EV-to-EBITDA for today is 6.83.
The historical rank and industry rank for Otsuka Holdings Co's EV-to-EBITDA or its related term are showing as below:
STU:OS1'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.22 Med: 10.12 Max: 18.72
Current: 6.93
During the past 13 years, the highest EV-to-EBITDA of Otsuka Holdings Co was 18.72. The lowest was 6.22. And the median was 10.12.
STU:OS1's EV-to-EBITDA is ranked better than 78.44% of 733
companies
in the Drug Manufacturers industry
Industry Median: 13.57
vs STU:OS1: 6.93
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Otsuka Holdings Co EV-to-EBITDA Historical Data
The historical data trend for Otsuka Holdings Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Otsuka Holdings Co's EV-to-EBITDA
For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otsuka Holdings Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Otsuka Holdings Co's EV-to-EBITDA falls into.
Otsuka Holdings Co's current Enterprise Value is €20,239 Mil.
Otsuka Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,962 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otsuka Holdings Co (STU:OS1) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Otsuka Holdings Co's PE Ratio (TTM) for today is calculated as:
Otsuka Holdings Co's share price for today is €39.80.
Otsuka Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.030.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Otsuka Holdings Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:OS1 has been successfully added to your 